Table 1 The clinical and demographical characteristics of pulmonary carcinoid cases
Cases for DASL-miRNA (N=47) | Cases for DASL-mRNA (N=51) | Cases for RNA-seq & Exon-seq (N=9) | |
|---|---|---|---|
Age at diagnosis | |||
N | 47 | 51 | 9 |
Mean (SD) | 62.2 (17.0) | 63.0 (16.3) | 57.4 (18.5) |
Gender | |||
Female | 31 (65.9%) | 35 (68.6%) | 6 (66.7%) |
Male | 16 (34.1) | 16 (31.4%) | 3 (33.3%) |
Cell type | |||
Typical | 44 (93.6%) | 48(94.1%) | 8 (88.9%) |
Atypical | 3 (6.4%) | 3(5.9%) | 1 (11.1%) |
Tumor stage | |||
Stage I & II | 36 (76.6%) | 40 (78.4%) | 9 (100%) |
Stage III & IV | 11 (23.4%) | 11 (21.6%) | 0 (0%) |
Sample set | |||
FFPE | 23 (48.9%) | 26 (50.9%) | -- |
FF | 24 (51.0%) | 25 (49.0%) | 9 (100%) |
Median follow-up period ( year ) | 6.4 | 6.4 | 7.2 |
Events | |||
Yes | 5 (10.6%) | 5 (9.8%) | 0 (0.00%) |
No | 42 (89.4%) | 46 (90.2%) | 9 (100%) |